Overview

Randomized Trial of Fluticasone in Bronchial Premalignancy

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of fluticasone on the development of lung cancer in smokers
Phase:
Phase 2
Details
Lead Sponsor:
VU University Medical Center
Collaborators:
GlaxoSmithKline
The Netherlands Cancer Institute
Treatments:
Fluticasone
Xhance